Categories: Alzheimer's disease

6/14/2018

No, an asthma drug tested in mice does not bring ‘new hope’ for Alzheimer’s patients, at least not yet

2 3/28/2018

‘Daily ibuprofen can prevent Alzheimer’s disease’ and other unproven claims by Canadian neuroscientist

8/24/2017

Retinal imaging detects biomarker for Alzheimer’s: Novel yes, but practical?

1 10/28/2016

Alzheimer’s drug study missed the primary endpoint; PR release touts benefits anyway

8/8/2016

News release on biochip blood test for Alzheimer’s risk oversells its practicality for patients

7/21/2016

Mayo release touts estrogen patch for reducing Alzheimer’s. But the study looked only at a risk marker.

1 6/22/2016

PR release claiming memory loss reversal in Alzheimer’s disease impaired by study limitations, imprecise language

3/15/2016

Nutritional drink to protect memory in ‘early Alzheimer’s’? Release takes us for a spin

3/4/2016

Serious harms from deep brain stimulation completely ignored in PR release

2/25/2016

Can an Alzheimer’s drug help you quit smoking? Penn PR release nicely frames very early research

News Release Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Alan Cassels @AKECassels·

Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597

Reply on Twitter 1361431489326407680 Retweet on Twitter 13614314893264076806 Like on Twitter 13614314893264076808 Twitter 1361431489326407680

Retweet on Twitter HealthNewsReview.org Retweeted

RxISK @RxISK·

A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.

It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123

Reply on Twitter 1361420459284131843 Retweet on Twitter 13614204592841318439 Like on Twitter 136142045928413184319 Twitter 1361420459284131843

HealthNewsReview.org @HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532 Retweet on Twitter 13602149497049825325 Like on Twitter 136021494970498253210 Twitter 1360214949704982532